Clinical trial
One-year Prospective Observational Study of BMI Change Effect of 5-alpha…
NCT00472251 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00472251 |
|---|---|
| Title | One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients |
| Official title | One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients |
| Lead sponsor | Seoul National University Hospital, Other |
| Collaborators | GlaxoSmithKline Industry Seoul National University Bundang Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | Benign Prostatic Hyperplasia |
| Enrollment | 120 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 11, 2007 |
| Last update posted | Jul 21, 2011 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: